Sunday, 24 October 2010

Mirtazapine Sandoz




Mirtazapine Sandoz may be available in the countries listed below.


Ingredient matches for Mirtazapine Sandoz



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapine Sandoz in the following countries:


  • Australia

  • Belgium

  • France

  • Lithuania

  • Netherlands

International Drug Name Search

Friday, 22 October 2010

Voltex




Voltex may be available in the countries listed below.


Ingredient matches for Voltex



Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Voltex in the following countries:


  • Myanmar

Methyl Salicylate

Methyl Salicylate is reported as an ingredient of Voltex in the following countries:


  • Myanmar

International Drug Name Search

Thursday, 21 October 2010

ATP Sanwa Kagaku




ATP Sanwa Kagaku may be available in the countries listed below.


Ingredient matches for ATP Sanwa Kagaku



Adenosine Triphosphate

Adenosine Triphosphate disodium salt (a derivative of Adenosine Triphosphate) is reported as an ingredient of ATP Sanwa Kagaku in the following countries:


  • Japan

International Drug Name Search

Tuesday, 19 October 2010

Rowasa


Generic Name: mesalamine (Rectal route)

me-SAL-a-meen

Commonly used brand name(s)

In the U.S.


  • Canasa

  • Rowasa

  • sfRowasa

In Canada


  • Mesasal

  • Pentasa

  • Salofalk

Available Dosage Forms:


  • Suppository

  • Enema

Therapeutic Class: Gastrointestinal Agent


Chemical Class: Salicylate, Non-Aspirin


Uses For Rowasa


Mesalamine is used to treat inflammatory bowel disease, such as ulcerative colitis. This medicine works inside the bowel by helping to reduce inflammation and other symptoms.


Mesalamine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, mesalamine is used in certain patients with the following medical condition:


  • Ulcerative colitis, history of—prevent it from occurring again

Before Using Rowasa


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of mesalamine in children with use in other age groups.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of mesalamine in the elderly with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Varicella Virus Vaccine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ardeparin

  • Certoparin

  • Dalteparin

  • Danaparoid

  • Enoxaparin

  • Nadroparin

  • Parnaparin

  • Reviparin

  • Tamarind

  • Tinzaparin

  • Warfarin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Kidney disease—The use of mesalamine may make this condition worse.

Proper Use of mesalamine

This section provides information on the proper use of a number of products that contain mesalamine. It may not be specific to Rowasa. Please read with care.


For best results, empty your bowel just before using the rectal enema or suppository.


Keep using this medicine for the full time of treatment even if you begin to feel better after a few days. Do not miss any doses.


For patients using the enema form of this medicine:


  • This medicine usually comes with patient directions. Read them carefully before using this medicine.

  • Remove the bottles from the protective foil pouch, being careful not to squeeze or puncture them. The enema is an off-white to tan color. Contents of the enemas removed from the foil pouch may darken with time. Slight darkening will not affect the potency of the contents. However, enemas with dark brown contents should be discarded.

  • Shake the bottle well to make sure that the medication is thoroughly mixed. Remove the protective cover from the applicator tip. Hold bottle at the neck so that no medicine spills out.

  • Lie on your left side with your left leg straight and your right knee bent in front of you for balance. You can also lie in the knee-chest position, on your knees with your chest touching the bed.

  • Gently insert the rectal tip of the enema applicator pointed slightly toward your naval to prevent damage to the rectal wall. Tilt the nozzle slightly toward the back and squeeze slowly to cause the enema to flow into your rectum. Steady pressure will discharge most of the medicine. After administering, withdraw and discard the bottle.

  • Remain in position for at least 30 minutes to allow the medicine to distribute thoroughly. Retain the medicine all night if possible.

For patients using the suppository form of this medicine:


  • This medicine usually comes with patient directions. Read them carefully before using this medicine.

  • Detach one suppository from strip of suppositories. Hold suppository upright and carefully remove the foil wrapper.

  • Avoid excessive handling of the suppository, which is designed to melt at body temperature.

  • Insert suppository (pointed end first) completely into rectum with gentle pressure. Retain the suppository for 3 hours or longer, if possible, to achieve the best result.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For inflammatory bowel disease:
    • For enema dosage form:
      • Adults and teenagers—4 grams (1 unit), used as directed, every night for three to six weeks.

      • Children—Use and dose must be determined by your doctor.


    • For suppository dosage form:
      • Adults and teenagers—500 milligrams (mg), inserted into your rectum, two or three times a day for three to six weeks or 1000 mg, inserted into your rectum, one time a day at bedtime for three to six weeks.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Rowasa


It is important that your doctor check your progress at regular visits.


Contact your doctor if you develop cramping, acute abdominal pain, bloody diarrhea, fever, headache or rash. These may be symptoms of a serious condition.


Tell your doctor right away if you experience chest pain or shortness of breath.


Check with your doctor if you notice rectal bleeding, blistering, pain, burning, itching, or other sign of irritation not present before you started using this medicine.


Mesalamine rectal enema may stain clothing, fabrics, painted surfaces, marble, granite, vinyl, or other surfaces it touches.


Rowasa Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


Less common or rare
  • Abdominal or stomach cramps or pain (severe)

  • anxiety

  • back pain (severe)

  • bloody, black, or tarry stools

  • blue or pale skin

  • bright red blood in the stool

  • chest pain, possibly moving to the left arm, neck, or shoulder

  • chills

  • diarrhea (severe)

  • fast heartbeat

  • fever

  • headache (severe)

  • nausea or vomiting

  • shortness of breath

  • skin rash

  • stomach cramps, tenderness, pain

  • swelling of the stomach

  • unusual tiredness or weakness

  • watery or bloody diarrhea

  • yellow eyes or skin

Incidence not known
  • Blood in urine

  • change in frequency of urination or amount of urine

  • cough

  • difficulty in breathing

  • drowsiness

  • high fever

  • increased thirst

  • loss of appetite

  • lower back or side pain

  • painful or difficult urination

  • pale skin

  • sore throat

  • sores, ulcers, or white spots on lips or in mouth

  • swelling of feet or lower legs

  • swollen glands

  • troubled breathing

  • unexplained or unusual bleeding or bruising

  • weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Abdominal or stomach cramps or pain (mild)

  • gas or flatulence

  • headache (mild)

  • nausea

Less common or rare
  • Acne

  • diarrhea

  • dizziness

  • leg or joint pain

  • loss of hair

  • rectal pain or irritation

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Rowasa side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Rowasa resources


  • Rowasa Side Effects (in more detail)
  • Rowasa Use in Pregnancy & Breastfeeding
  • Rowasa Drug Interactions
  • Rowasa Support Group
  • 5 Reviews for Rowasa - Add your own review/rating


  • Rowasa Prescribing Information (FDA)

  • Rowasa Enema MedFacts Consumer Leaflet (Wolters Kluwer)

  • Mesalamine Prescribing Information (FDA)

  • Mesalamine Controlled-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Mesalamine Monograph (AHFS DI)

  • Apriso Prescribing Information (FDA)

  • Apriso Consumer Overview

  • Apriso Extended-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Asacol Delayed-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Asacol Consumer Overview

  • Asacol Prescribing Information (FDA)

  • Asacol HD Prescribing Information (FDA)

  • Asacol HD Delayed-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Canasa Prescribing Information (FDA)

  • Canasa Suppositories MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lialda Prescribing Information (FDA)

  • Lialda Consumer Overview

  • Pentasa Prescribing Information (FDA)

  • Pentasa Consumer Overview

  • sfRowasa Prescribing Information (FDA)



Compare Rowasa with other medications


  • Crohn's Disease
  • Inflammatory Bowel Disease
  • Ulcerative Colitis
  • Ulcerative Colitis, Active
  • Ulcerative Proctitis

Saturday, 16 October 2010

Perskindol




In the US, Perskindol is a member of the drug class topical anesthetics and is used to treat Cough and Pain.

Ingredient matches for Perskindol



Levomenthol

Levomenthol is reported as an ingredient of Perskindol in the following countries:


  • Switzerland

International Drug Name Search

Thursday, 14 October 2010

Amikacin Injection Meiji




Amikacin Injection Meiji may be available in the countries listed below.


Ingredient matches for Amikacin Injection Meiji



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amikacin Injection Meiji in the following countries:


  • Thailand

International Drug Name Search

Sunday, 10 October 2010

Sandoz Co-Tenidone




Sandoz Co-Tenidone may be available in the countries listed below.


Ingredient matches for Sandoz Co-Tenidone



Atenolol

Atenolol is reported as an ingredient of Sandoz Co-Tenidone in the following countries:


  • South Africa

Chlortalidone

Chlortalidone is reported as an ingredient of Sandoz Co-Tenidone in the following countries:


  • South Africa

International Drug Name Search

Saturday, 9 October 2010

Aurene




Aurene may be available in the countries listed below.


Ingredient matches for Aurene



Oxcarbazepine

Oxcarbazepine is reported as an ingredient of Aurene in the following countries:


  • Argentina

International Drug Name Search

Friday, 8 October 2010

deferasirox


dee-FER-a-sir-ox


Oral route(Tablet for Suspension)

May cause renal impairment (including failure), hepatic impairment (including failure), and gastrointestinal hemorrhage. In some reported cases, these reactions were fatal. These reactions were more frequently observed in patients with advanced age, high risk myelodysplastic syndromes (MDS), underlying renal or hepatic impairment or low platelet counts (less than 50 x 10(9)/L). Therapy requires close patient monitoring, including laboratory tests of renal and hepatic function .



Commonly used brand name(s)

In the U.S.


  • Exjade

Available Dosage Forms:


  • Tablet for Suspension

Therapeutic Class: Heavy Metal Chelator


Uses For deferasirox


Deferasirox is used to remove excess iron from the body after a person has had too many blood transfusions.


Deferasirox combines with iron in the blood. The combination of iron and deferasirox is then removed from the body by the kidneys. If you have too much iron in the body, it can damage various organs and tissues.


deferasirox is available only with your doctor's prescription.


Before Using deferasirox


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For deferasirox, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to deferasirox or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of deferasirox in children up to 2 years of age. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of deferasirox in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution in patients receiving deferasirox.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking deferasirox, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using deferasirox with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Paclitaxel

  • Theophylline

Using deferasirox with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Cholestyramine

  • Midazolam

  • Repaglinide

  • Rifampin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Other Medical Problems


The presence of other medical problems may affect the use of deferasirox. Make sure you tell your doctor if you have any other medical problems, especially:


  • Blood or bone marrow disorders (e.g., agranulocytosis, neutropenia) or

  • Eye problems (e.g., cataracts, glaucoma) or

  • Hearing problems or

  • Kidney disease or

  • Stomach ulcers or bleeding problems—Use with caution. May make these conditions worse.

  • Bone marrow problems (e.g., myelodysplastic syndrome) or

  • Cancer or

  • Kidney disease, severe or

  • Liver disease, severe or

  • Thrombocytopenia (low platelet count in the blood)—Should not be used in patients with these conditions.

  • Liver disease (e.g., hepatitis)—You may need a lower dose of deferasirox.

Proper Use of deferasirox


It is best to take deferasirox at the same time each day on an empty stomach, at least 30 minutes before you eat.


Dissolve the tablet in water, orange juice, or apple juice, mix well, then drink the mixture right away. To make sure you get all of the medicine, add some more liquid to the drinking glass, then drink all of this liquid too. Do not chew or swallow the tablet whole, and do not use it without mixing it in a liquid first.


Dosing


The dose of deferasirox will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of deferasirox. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (tablet for suspension):
    • For chronic iron overload:
      • Adults and children over 2 years of age—Dose is based on body weight and must be determined by your doctor. The usual starting dose is 20 milligrams (mg) per kilogram (kg) of body weight per day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 40 mg per kg per day.

      • Children younger than 2 years of age—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of deferasirox, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using deferasirox


It is very important that your doctor check your or your child's progress at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it. Blood and urine tests may be needed to check for unwanted effects.


Deferasirox may cause some people to have hearing and vision problems within a few weeks after they start taking it. If you or your child notice any problems with your hearing or vision, such as blurred vision, difficulty with night vision, or difficulty with seeing colors, check with your doctor as soon as possible.


deferasirox may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you or your child have a rash; itching; hoarseness; trouble breathing; trouble swallowing; or any swelling of your hands, face, or mouth while you are using deferasirox.


Deferasirox will lower the number of some types of blood cells in your body. Because of this, you or your child may bleed or get infections more easily. To help with these problems, avoid being near people who are sick or have infections. Wash your hands often. Stay away from rough sports or other situations where you could be bruised, cut, or injured. Brush and floss your teeth gently. Be careful when using sharp objects, including razors and fingernail clippers.


Stop using deferasirox and check with your doctor right away if you or your child have the following symptoms: agitation, confusion, decreased urine output, lethargy, muscle twitching, rapid weight gain, seizures, or swelling of the face, ankles, or hands. These may be symptoms of a serious kidney problem.


Liver problems may occur while you are using deferasirox. Stop using deferasirox and check with your doctor right away if you or your child are having more than one of these symptoms: abdominal or stomach pain or tenderness; clay-colored stools; dark urine; fever; nausea and vomiting; skin rash; or yellow eyes or skin.


Check with your doctor right away if you or your child have these symptoms: abdominal or stomach pain, cramping, or burning; black, tarry stools; constipation; diarrhea; heartburn; indigestion; nausea; or vomiting of blood or material that looks like coffee grounds. These may be symptoms of a serious stomach or bowel problem.


Serious skin reactions can occur with deferasirox. Stop using deferasirox and check with your doctor right away if you have blistering, peeling, or loosening of the skin; red skin lesions; sores or ulcers on the skin; or fever or chills while you or your child are using deferasirox.


If you or your child have diarrhea or vomiting, drink plenty of water or fluids to keep your body hydrated.


deferasirox may cause some people to become dizzy. Do not drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements. Do not take deferasirox with aluminum-containing antacids (Mylanta®, Maalox®).


deferasirox Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Body aches or pain

  • chills

  • congestion

  • cough or cough producing mucus

  • diarrhea

  • difficulty with breathing

  • difficulty with moving

  • dryness or soreness of the throat

  • earache or pain in the ear

  • ear drainage

  • fever with or without chills

  • general feeling of discomfort or illness

  • headache

  • hoarseness

  • joint pain

  • loss of appetite

  • muscle aches and pains

  • nausea

  • shivering

  • shortness of breath

  • stuffy or runny nose

  • tender, swollen glands in the neck

  • tightness in the chest

  • trouble with sleeping

  • trouble with swallowing

  • unusual tiredness or weakness

  • voice changes

  • vomiting

  • wheezing

Rare
  • Blindness

  • blurred vision

  • change in hearing

  • change in vision

  • decreased hearing

  • decreased vision

  • high-frequency hearing loss

  • loss of vision

  • pain or discomfort in the eye

  • white area over the eye

Incidence not known
  • Agitation

  • black, tarry stools

  • bleeding gums

  • blood in the urine or stools

  • confusion

  • decrease in urine amount

  • depression

  • difficulty with swallowing

  • dizziness

  • fast heartbeat

  • hives or welts

  • hostility

  • irritability

  • itching

  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • lethargy

  • lower back or side pain

  • muscle twitching

  • painful or difficult urination

  • pale skin

  • pinpoint red spots on the skin

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • rapid weight gain

  • redness, soreness or itching of the skin

  • seizures

  • skin rash

  • sore throat

  • sores, ulcers, or white spots on the lips or in the mouth

  • sores, welting, or blisters

  • stupor

  • swelling of face, ankles, or hands

  • unusual bleeding or bruising

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Abdominal or stomach pain

  • back pain

  • muscle stiffness

Incidence not known
  • Hair loss or thinning of the hair

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: deferasirox side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More deferasirox resources


  • Deferasirox Side Effects (in more detail)
  • Deferasirox Use in Pregnancy & Breastfeeding
  • Deferasirox Drug Interactions
  • Deferasirox Support Group
  • 0 Reviews for Deferasirox - Add your own review/rating


  • Deferasirox Professional Patient Advice (Wolters Kluwer)

  • Deferasirox Monograph (AHFS DI)

  • Deferasirox MedFacts Consumer Leaflet (Wolters Kluwer)

  • Exjade Prescribing Information (FDA)

  • Exjade Consumer Overview



Compare deferasirox with other medications


  • Hemosiderosis

Thursday, 7 October 2010

Atomoderma A




Atomoderma A may be available in the countries listed below.


Ingredient matches for Atomoderma A



Retinol

Retinol is reported as an ingredient of Atomoderma A in the following countries:


  • Argentina

International Drug Name Search

Monday, 4 October 2010

Bemedrex Easyhaler




Bemedrex Easyhaler may be available in the countries listed below.


Ingredient matches for Bemedrex Easyhaler



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Bemedrex Easyhaler in the following countries:


  • France

International Drug Name Search

Saturday, 2 October 2010

Sinvat




Sinvat may be available in the countries listed below.


Ingredient matches for Sinvat



Simvastatin

Simvastatin is reported as an ingredient of Sinvat in the following countries:


  • Italy

International Drug Name Search

Friday, 1 October 2010

Permyo




Permyo may be available in the countries listed below.


Ingredient matches for Permyo



Eperisone

Eperisone hydrochloride (a derivative of Eperisone) is reported as an ingredient of Permyo in the following countries:


  • Indonesia

International Drug Name Search